In vitro study demonstrates precise electrochemical control of insulin secretion in cultured pancreatic beta-cells, highlighting a framework for digital-to-analog biointerfaces.
Interfaces that convert digitally defined signals into biological analog functions (D/A biointerfaces) remain underdeveloped compared with biosensors that digitize biological analog information (A/D biointerfaces). Here, we report direct electrochemical control of insulin secretion through membrane-potential modulation using a stable tetraethyl orthosilicate (TEOS)–incorporated PEDOT:PSS electrode that supports long-term culture of pancreatic β-cells as a model endocrine system. β-cells expressing luminescent insulin (iGL cells) were cultured on the electrode, and secretion dynamics were monitored by luminescence imaging during potential application. Application of +500 mV relative to the resting electrode potential (REST) rapidly reduced luminescence, indicating insulin release within seconds. Following this potential application, cells remained viable after additional culture for 3 days, retaining insulin synthesis and the ability to respond to subsequent induction. Fluorescence imaging with the membrane-potential dye FluoVolt™ suggested that the application of REST +200 mV induced depolarization comparable to that generally reported for activation of voltage-gated Ca 2+ channels. Following a brief induction period, reapplication of the REST potential halted secretion. Alternating induction and REST pulses enabled stepwise modulation of cumulative insulin release. These results provide a basic operational principle for D/A biointerfaces that translate digitally programmed electrochemical inputs into analog, graded hormonal outputs.
No takes yet. Share an insight, caveat, or question.
Shigematsu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: